4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0001193125-26-323754
Director sold 261,460 shares at an average $25.51 ($6,670,769)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X06/ownership.xml…